Danish Chemicals Stock News

FLSmidth & Co. A/S ( CPH:FLS ) shareholders have had their patience rewarded with a 25% share price jump in the last...

Danske Bank A/S' ( CPH:DANSKE ) dividend will be increasing from last year's payment of the same period to DKK22.72 on...

It's been a mediocre week for Vestas Wind Systems A/S ( CPH:VWS ) shareholders, with the stock dropping 15% to kr.165...

Pandora A/S ( CPH:PNDORA ) has announced that it will be increasing its dividend from last year's comparable payment on...

Coloplast Q1 2026 Earnings Snapshot Coloplast (CPSE:COLO B) opened its 2026 financial year with Q1 revenue of DKK 7.0b and basic EPS of DKK 6.21, alongside trailing twelve month EPS of DKK 17.70 and net income of DKK 4.0b. Over recent quarters the company has seen quarterly revenue move in a tight band between DKK 6.9b and DKK 7.0b, while quarterly EPS has ranged from DKK 3.57 to DKK 6.21 as net income shifted between DKK 805m and DKK 1.40b. This sets up this report as a check-in on how much...

The board of Novo Nordisk A/S ( CPH:NOVO B ) has announced that it will be paying its dividend of DKK7.95 on the 31st...

The ChemoMetec A/S ( CPH:CHEMM ) share price has fared very poorly over the last month, falling by a substantial 40...

It's been a good week for Danske Bank A/S ( CPH:DANSKE ) shareholders, because the company has just released its latest...

There's been a notable change in appetite for GN Store Nord A/S ( CPH:GN ) shares in the week since its yearly report...

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.3% to close at kr.87.90 following the...

Ørsted (CPSE:ORSTED) closed out FY 2025 with Q4 revenue of DKK23.1b and a basic EPS loss of DKK1.77, while trailing twelve month EPS sat at DKK1.95 on revenue of DKK73.2b. Over recent periods the company has seen quarterly revenue range from DKK12.3b to DKK23.1b and EPS swing from a profit of DKK10.57 in Q1 2025 to losses in Q3 and Q4. Investors are watching how consistently that full year profitability holds up. With trailing net income of DKK1.7b against those sizable top line figures, the...

One of the biggest stories of last week was how Novo Nordisk A/S ( CPH:NOVO B ) shares plunged 20% in the week since...

It's been a sad week for H. Lundbeck A/S ( CPH:HLUN B ), who've watched their investment drop 11% to kr.37.46 in the...

There's been a major selloff in ChemoMetec A/S ( CPH:CHEMM ) shares in the week since it released its interim report...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...

Danske Bank (CPSE:DANSKE) has wrapped up FY 2025 with fourth quarter revenue of DKK 15.2b and basic EPS of DKK 7.73, supported by trailing twelve month revenue of DKK 56.5b and EPS of DKK 27.94 that frame the latest print in a wider earnings run rate. That backdrop of steady headline revenue and EPS trends sets up a results season where the key question for you is how far the current profitability mix, including modestly softer margins, aligns with the rewards and risks already on your...

Pandora (CPSE:PNDORA) is shifting its core jewelry offering from silver based products to platinum plated pieces, aiming to reduce exposure to swings in silver prices. The company is pausing its share buyback program as it reallocates capital toward this product overhaul. Pandora is also reshaping its leadership team, including the appointment of a new chief product officer, to support the transition. Pandora, known globally for its charm bracelets and accessible jewelry, is moving its...

Demant (CPSE:DEMANT) has drawn fresh attention after its 2025 results combined softer net income with a cautious 2026 outlook and a plan to cut 700 jobs, prompting a sharp share price reaction. See our latest analysis for Demant. The latest earnings announcement, cautious 2026 guidance and cost saving plan have come on top of a weak run for the shares, with a 7 day share price return of 14.61% decline and a 1 year total shareholder return of 28.98% decline pointing to fading momentum. If...

Carlsberg (CPSE:CARL B) has posted its FY 2025 numbers with second half revenue of DKK 43.2b, basic EPS of DKK 18.10 and net income of DKK 2,393m, while the first half delivered revenue of DKK 45.9b, basic EPS of DKK 26.95 and net income of DKK 3,562m. The company has seen first half revenue move from DKK 38.8b in 2024 with basic EPS of DKK 28.08 and net income of DKK 3,739m to DKK 45.9b in 2025, which sets the scene for investors to focus on how current margins and expectations for future...

If you are wondering whether Vestas Wind Systems is still attractively priced after its recent run, this article will help you unpack what the current share price might be implying about future expectations. The stock trades at DKK 176.4 after a 6.1% decline over the last 7 days and a 5.8% decline over the last 30 days, although the 1 year return sits at 65.9%. These moves come as Vestas continues to be a focal point in global wind power discussions, with investors paying close attention to...

Wondering whether Carlsberg’s current share price really reflects what you are getting as an investor? This article walks through the numbers so you can judge the value for yourself. Carlsberg’s shares last closed at DKK 939.0, with returns of 10.2% over 7 days, 13.5% over 30 days, 13.7% year to date, 22.2% over 1 year, 5.9% over 3 years and 11.7% over 5 years. This provides useful context before thinking about what the stock might be worth. Recent coverage around Carlsberg has focused on...

Embla Medical hf (CPSE:EMBLA) has wrapped up FY 2025 with fourth quarter revenue of US$256.7 million and basic EPS of US$0.058, on trailing twelve month revenue of US$928.7 million and EPS of US$0.196 that frame the latest print. Over recent periods the company has seen revenue move from US$224.8 million and EPS of roughly US$0.044 in Q4 2024 to US$256.7 million and EPS of US$0.058 in Q4 2025, with trailing net income rising from US$68.3 million to US$83.3 million. This sets up a story where...

Demant A/S has released its full-year 2025 results, reporting sales of DKK 22,971 million, up from DKK 22,419 million a year earlier, while net income fell to DKK 1,545 million and basic earnings per share from continuing operations declined to DKK 11.2. The combination of higher sales but lower net income and earnings per share highlights shifting cost, margin or mix effects that may reshape how investors view Demant’s underlying earnings quality. We’ll now examine how Demant’s higher sales...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...